The Impacts of Subthalamic Nucleus-Deep Brain Stimulation (STN-DBS) on the Neuropsychiatric Function of Patients with Parkinson’s Disease Using Image Features of Magnetic Resonance Imaging under the Artificial Intelligence Algorithms
Open Access
- 8 July 2021
- journal article
- research article
- Published by Hindawi Limited in Contrast Media & Molecular Imaging
- Vol. 2021, 1-7
Abstract
This study was to explore the effect of subthalamic nucleus- (STN-) deep brain stimulation (DBS) on the neuropsychiatric function of Parkinson’s disease (PD) patients using the magnetic resonance imaging (MRI) image analysis technology and the artificial intelligence (AI) algorithm. In this study, 40 PD patients admitted to our hospital from August 2018 to March 2020 were selected as the research objects, and they were divided into a control group and an observation group according to the random number table method, with 20 cases in each group. The patients in the control group were given oral treatment with levodopa tablets; and patients in the observation group were treated with STN-DBS + levodopa tablets. In patients, MRI examinations were performed before and after the treatment, and the image optimization processing algorithm under AI was adopted to process the images. The MRI imaging results of the two groups of patients were observed, analyzed, and compared before and after treatment; and the sports, cognition, and mental states of the two groups of patients were analyzed. It was believed that the MRI image before using the AI algorithm was blurry, and the image was clear after the noise reduction optimization process, which was convenient for observation. The data analysis revealed that the signal-to-noise ratio (SNR) after denoising (32.41) and structural similarity (SSIM) (0.79) had been improved. The results of the study suggested that the space occupation and bleeding symptoms of the two groups of patients were reduced after treatment, and those in the observation group were better than those of the control group; the incidences of dyskinesia and motor symptom fluctuations in the observation group were 5% and 0%, respectively, which were lower than those in the control group (35% and 25%, respectively). After treatment, the Unified Parkinson’s Disease Rating Scale (UPDRS) score of the two groups of patients decreased, and it was lower in the observation group than in the control group; and the Montreal Cognitive Assessment (MoCA) and Mini-Mental State Scale (MMSE) scores increased, and those in the observation group were higher in contrast to those in the control group (all P < 0.05 ). STN-DBS was beneficial to improve the clinical symptoms of patients and delay the progress of the disease, and MRI based on AI algorithms can effectively observe the changes in the neuropsychiatric function of patients, which was conducive to further clinical diagnosis and treatment.Keywords
This publication has 20 references indexed in Scilit:
- Interaction Between Neuropsychiatric Symptoms and Cognitive Performance in Parkinson’s Disease: What Do Clinical and Neuroimaging Studies Tell Us?Current Neurology and Neuroscience Reports, 2018
- Neuropsychiatric complications and neuroimaging characteristics after deep brain stimulation surgery for Parkinson’s diseaseBrain Imaging and Behavior, 2018
- Artificial Intelligence, Machine Learning, Deep Learning, and Cognitive Computing: What Do These Terms Mean and How Will They Impact Health Care?The Journal of Arthroplasty, 2018
- Adjunct zonisamide to levodopa for DLB parkinsonismNeurology, 2018
- Subthalamic stimulation and neuropsychiatric symptoms in Parkinson’s disease: results from a long-term follow-up cohort studyJournal of Neurology, Neurosurgery & Psychiatry, 2018
- Features of GBA-associated Parkinson’s disease at presentation in the UK Tracking Parkinson’s studyJournal of Neurology, Neurosurgery & Psychiatry, 2018
- Deep Learning Algorithms for Detection of Lymph Node Metastases From Breast CancerJAMA, 2017
- Effects of dopaminergic depletion and brain atrophy on neuropsychiatric symptoms in de novo Parkinson’s diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2017
- Imaging the Etiology of Apathy, Anxiety, and Depression in Parkinson’s Disease: Implication for TreatmentCurrent Neurology and Neuroscience Reports, 2017
- White matter pathology in Parkinson's disease: The effect of imaging protocol differences and relevance to executive functionNeuroImage, 2012